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Cardiovascular diseases are the main source of death and morbidity in developed and developing nations. 
Animal models are required to propel our understanding of the pathogenesis, increase our knowledge, 
disease progress, and mechanism behind cardiovascular disorder, providing new approaches focused to 
improve the diagnostic and the treatment of these pathological conditions and additionally to test various 
therapeutic ways to deal with tissue regeneration and re-establish heart working following damage. A 
perfect model framework ought to be reasonable, effectively controlled, reproducible, and physiologically 
illustrative of human disease, show cardinal signs and pathology that resembles after the human ailment 
and ethically stable. The decision of selection of animal model should be considered precisely since 
it influences exploratory results and whether results of the research can be sensibly matched with the 
human. In this way, no specific technique splendidly reproduces the human disease, and relying upon 
the model, extra cost burden, resources, infrastructure and the necessity for technical hands, should 
also be kept under consideration. Here we have discussed and compiled various methods of inducing 
myocardial infarction in animals, basically by surgery, chemicals and through genetic modification, this 
may benefit the researchers in getting a complied data regarding various methods through which they 
can induce myocardial infarction in animals.
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INTRODUCTION
Cardiovascular diseases are the most common 
and leading cause of morbidity and mortality across the 
world. CVD is a broad term which includes hypertension, 
coronary heart disease, congestive heart failure, and stroke. 
CVDs account 17.3 million deaths per annum globally 
(Reeve et al., 2005). Among all CVDs, Myocardial 
infarction (MI) is responsible for 10% of the total mortality 
(Alexander, Bruneau, 2010). In order to prevent and treat 
CHF more effectively, it is quite necessary to understand 
the pathophysiological mechanisms behind this disorder. 
Therefore, in vivo models closely related to the structural 
and functional characteristics of human CHF are used for 
analysis. However, to study all aspects of CHF a single 
model can’t be used as every animal model has some 
pros and cons. when an animal model is being established 
some technical points are to be considered such as model, 
species, strain and gender affecting the pathophysiology 
of the malfunctioning heart. The therapeutic objectives 
for the treatment of HF are focused on improving the 
patient’s quality of life, alleviating or reducing symptoms, 
preventing hospitalisation, slowing the progression of the 
illness and increasing the survival rate (Oliveira et al., 
2013).
The use of animals with medical and biological 
objectives has been practiced for centuries and 
this practice has added to our understanding and 
providing new methodologies focused to advance 
the diagnostic and treatment of certain pathologies. 
Areas of biomedical research, such as pharmacology, 
physiology, and toxicology, have based their progress 
in experiments carried out mainly in animal models or 
in the accurate observations of spontaneous phenomena 
in animals. The results obtained in animal models 
provide invaluable information for the design of tests 
for new pharmacological products in human beings. 
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The test of a new product in human beings must begin 
by experimenting on intact animals; this is apart from 
the tests in other models, such as cell culture. The 
improvement of animal models of cardiovascular disease 
(CVD), including heart and athero thrombotic problem, 
has furnished us today with vital experiences into the 
pathophysiology, and they were observed to be basic 
apparatuses to assess new remedial methodologies for 
their earlier prediction and to inhibit these complications 
(Chandrasekera, Pippin, 2015). Endothelial dysfunction 
is one of the main underlying pathophysiological 
alterations in cardiovascular disorders like hypertension, 
coronary artery disease and heart failure (Páez et al., 
2013). Coronary artery ligation is a most commonly 
utilized model of causing myocardial infarction for 
identification of drugs, cells or proteins. In this system, 
scientist stated that initially a thoracotomy is performed 
on the anesthetized animal, and the heart is quickly 
exteriorized by applying little pressure on the right side 
of the chest cavity. The coronary vein is either ligated or 
occluded up between the pulmonary artery outpouring 
tract and the left ventricle. The heart is then placed back 
to its ordinary position and the thorax is promptly closed 
(Zaragoza et al., 2011).
There are two principle ligation models, left anterior 
descending artery (LAD) ligation to instigate a myocardial 
infarction (MI) and a brief coronary artery impediment 
to incite ischemia/reperfusion damage (IR) (Gao et al., 
2011). Obviously one disadvantage is that animals 
have dissimilar physiologies when compared to human 
(Halapas et al., 2008) so as scientist we should think 
about this. However there are a few advantages to this 
model method, for example, undamaged pectoral muscles, 
which is huge in light of the fact that these muscles are 
basic to cover the opening once the heart has been come 
back to the thoracic cavity and restrain the sewing of the 
muscle. Aside from surgical strategies MI can be prompted 
by different chemicals, for example, catecholamines, 
cytotoxic medications particularly anthracyclines. Quality 
knockout animal models have ended up being an essential 
segment in conjunction with transgenic lines of mice as a 
method for producing “human similar” mouse models as a 
component of new drug discovery systems (Klocke et al., 
2007). 
Here, we have summarized the various common 
methods for induction of Myocardial infarction, including 
those implemented in both large and small animals, 
designed for helping to cover with more precision and 
to better understand every single aspect related to these 
human pathologies.
Methods of induction of myocardial infarction
There are various methods for induction of 
Myocardial Infarction both via In vitro and in vivo 
methods. An accurate MI model should be beneficial for 
an accurate targeting of the various parameters (Figure 1).
In vitro 
Coronary artery ligation in isolated working rat heart
Coronary artery ligation followed by reperfusion
Langendorff Heart Model
In vitro models -Isolated Cardiac Cells
In vivo
Left anterior descending (LAD) coronary artery 
ligation
Left ventricular MI
Myocardial Ischaemia followed by Reperfusion
•	Coronary artery ligation followed by reperfusion
•	Minimal Invasive Ischaemia/Reperfusion Model








a) Knockout Mouse Model: 




FIGURE 1 - Various methods for Induction of Myocardial 
Infarction
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In vitro 
Coronary artery ligation in isolated working rat 
heart
In functioning heart arrangement of rats, ischemia 
can be caused by tying the left coronary artery starting at 
its origin. After the clip has been removed, differences in 
the reperfusion period can be clearly seen. Measures taken 
to prevent these symptoms can be used to define efficacy 
of cardiac drugs (Vogel, 2007). 
Wistar rats weighing 280-300 g of either sex are 
sacrificed by decapitation. The hearts are removed and made 
free from surrounding connective tissue and epicardium. A 
cannula is inserted in the aorta according to the Langendorff 
technique from where the coronary vessels are perfused 
along the nonrecirculated perfusion medium. Inside the left 
ventricle a balloon is closely fitted in the ventricular cavity 
and joined to an artificial systemic circulation. By the help 
of a cannula fluid present in the balloon is pumped into the 
closed extra corporal circulation being forcefully pumped 
into a single direction by 2 recoil valves. Silicone material, 
Teflon form is used to prepare the balloon. The fluid volume 
ejected from the balloon during each heartbeat, is equal to 
the stroke volume of the heart, and it can be recorded by help 
of an integrator and flow meter probe connected in series. 
Afterload and preload can be adjusted independently from 
each other. The perfusate flow (reversely moving into the 
aorta and through the coronary arteries is discretely recorded 
(Linz et al., 1986). In isolated rat hearts the following 
parameters were measured: 
LVP (left ventricular pressure) is measured 
with Statham pressure transducer P 23 DB, which on 
differentiation yielded HR (heart rate) and LV dp/dt max. 
Coronary flow (CF) and Cardiac output are measured by 
electromagnetic flow probes in the in the aortic cannula 
and outflow system, respectively. Coronary venous pO2 is 
determined by placing a catheter in the pulmonary artery 
by a type E 5046 electrode which is connected to a PMH 
73 pH/blood gas monitor (Radiometer). The recording of 
an epicardial electrocardiogram is obtained by the help of 
two silver electrodes attached to the heart. All parameters 
were recorded on a Brush 2600 recorder.
Myocardial  oxygen consumption (MWO 2) 
[mL/min/g wet weight] is calculated according to the 
equation: 
MVO2= CF x(Pa – Pv) x (c/760) x100 
where CF is the coronary flow [mL/min/g], Pa is the 
oxygen partial pressure of arterial perfusate (650 mm 
Hg), Pv is the oxygen partial pressure of the venous 
effluent perfusate [mm Hg], and c is the 0.0227 mL O2/mL 
perfusate representing the Bunsen solubility coefficient of 
oxygen dissolved in perfusate at 37 °C (Martorana et al., 
1987).
Coronary artery ligation followed by reperfusion
In coronary artery blocking experiment, over a time 
span of 20 min (pre-ischemic period), modified Krebs-
Henseleit buffer are perfused in isolated working hearts at 
a constant pressure of 65 mm Hg. After that, left coronary 
artery is clamped near its origin for 15 min resulting in 
acute myocardial ischemia. Thereafter, clip is released, and 
various changes in myocardium are monitored for 30 min 
(reperfusion period). Ventricular fibrillation is developed 
in heart after coronary artery and reperfusion. Lactate, 
lactate dehydrogenase (LDH), and creatine kinase (CK) 
are determined from the coronary ejected sample. 
Histopathological study can be done to estimate 
glycogen, ATP, creatine phosphate, lactate in the cardiac 
tissue. Before occlusion or 5 min before reperfusion 
the test drug are mixed into the perfusate. For ex vivo 
experiments, the rats are administered orally with the test 
drug just 1 hr before the isolated working heart preparation 
and sacrifice (Scholz et al., 1992; Scholz et al., 1993). The 
efficacy and potency of cardioprotective drug is compared 
with control after treatment of ventricular fibrillation. 
Angiotensin II reduces the LV dP/dt max, Left ventricular 
pressure, and coronary flow after coronary artery ligation 
and the myocardial content of glycogen, ATP and creatine 
phosphate are decreased due to increase in enzymatic 
metabolism in the effluent. Opposite effects are shown by 
the cardioprotective drugs. After completion the obtained 
data from each parameter is compared with control. 
Vleeming et al. (1989) performed thoracotomy in the 
presence of ether by tying the left coronary artery. After 
48 hr of surgery, by using Langendorff technique the heart 
was prepared for reversible constant pressure perfusion 
(Vleeming et al., 1989).
Igic introduced a new isolated working rats heart 
method in which a special designed double cannula is 
used, the outer cannula is inserted in the aorta and the 
inner cannula is inserted in the left ventricle. The perfusion 
fluid is allowed to reach left ventricle via inner cannula 
and is ejected out through aorta. When the outer cannula 
is closed the fluid passes through the coronary artery and 
oozes outside the heart. A small amount of perfusion 
fluid is perfused in the coronary artery and rest amount is 
expelled out, when a specific pressure resistance is applied 
and outer cannula is opened. Because the inner cannula can 
be easily removed from the outer cannula, which has been 
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inserted in the aorta, this setup provides an opportunity to 
use the same heart as a “working” or “nonworking” model 
for identifying the working of the heart (Igić, 1996).
Langendorff heart model
German physiologist Skar Langendorff first 
proposed isolated heart model in 1895 for the physiological 
and pharmacological experiment on isolated heart. This 
method or apparatus is worldwide known as the The 
Langendorff heart apparatus or model. The basic agenda 
of Langendorff model was to provide oxygen and 
necessary metabolite through a single cannula inserted in 
the ascending aorta. By the help of an external pump the 
perfusate or the oxygenated blood is pumped into the heart 
by the help of a pump via aorta. This continuous cyclic 
supply shuts the aortic valve and during diastole allows 
the fluid to flow via coronary artery. Fluid moves through 
the coronary system and exit out in the right auricle via 
coronary sinus. 0.5 - 1.5 Liters/min is the rate of coronary 
flow required normally for an adult human heart.
According to the perfusion system Langendorff 
assembly is of two types:
Langendorff mode - The flow of bloods and metabolites 
into coronaries artery is determined by the external 
pump.
Working mode - The flow of bloods and metabolites into 
coronaries artery is determined by the contraction 
and performance of the heart. It can also be used for 
in vivo perfusion (Kumar et al., 2016). In a standard 
langendorff assembly, the heart is clamped via aorta 
against the cannula. The cannula size for rats and mice 
varies from 14 to 8 gauge (1.6 -3.2 mm) to 22 and 16 
gauge (0.6-1.3 mm) respectively. Before administer-
ing anesthesia and starting the mounting of the heart, 
heparin is injected in animal in order to prevent blood 
coagulation. Commonly used anesthetics are Inject-
able (pentobarbital, ketamine/ xylazine) and inhalable 
(isoflurane). The level of creatine phosphate and ATP 
decline rapidly in isolated heart that why cannulation 
process is done as soon as possible with the help of 
magnifying glass or section microscope in the perfu-
sion system (de Leiris, Harding, Pestre, 1984). The 
degree of ischemia produced in the heart, directly de-
pends and controlled by partial or complete blockage 
of blood supply to the heart. The molecular pathway 
in ischemia reperfusion injury can be understood by 
this method (Verdouw et al., 1998; Hernando et al., 
2010).
Murry et al .  (1986) explained the ischemic 
preconditioning phenomenon by using ex-vivo 
langendorff heart model, and stated that irreversible 
myocardial injury can be delayed, if the ligation 
was presage by the small duration of reversible 
myocardial ischemia (Murry, Jennings, Reimer, 
1986). The entire procedure is summarised as, 
without flow of fluid (no flow) the ventricles 
contract and the left chambers of the heart is allowed 
to remain filled. According to Frank-Starling 
principle, the pressure inside the ventricles of heart 
is directly proportional to the force of contraction, 
In order to create a more physiological contraction 
of ventricles many scientist have tried to increase 
pressure inside the left ventricle. For example, 
the force of contraction and ventricular pressure 
has been increased by placing inflated balloon 
in the ventricles. Similarly, pressures have been 
increased by filling fluid in the ventricle while 
atrioventricular clamp has been used to prevent 
valvular regurgitation.
Following are the some advantages on in vivo MI 
models such as, 
•	 Easy to understand the pathophysiological changes 
•	 Well controlled environmental conditions
•	 Elimination of hemodynamic neurohumoral hin-
drances
Initially, the Visible Heart preparation depends upon 
constant pressure Langendorff perfusion inorder to supply 
the adequate oxygen and metabolites to cardiac muscles. 
However, without the presence of major arrhythmias, 
as the normal sinus rhythm has been achieved for long 
interval of time, the heart can be transferred into 4 chamber 
working model and Langendorff perfusion is stopped or 
re-established as required (Verdouw et al., 1998).
In vitro models - isolated cardiac cells
In in vitro models complete body or intrinsic impacts, 
for example, the extracellular condition, are removed. Less 
complicated frameworks offer several circumstances 
including giving the capacity to control and repeat disease 
pathology utilizing latest progressed natural procedures to 
additionally figure out disease pathology. Besides, in-vitro 
results give information which can be further approved by 
in-vivo work, this may refine the research procedure and as 
such favours the less use of experimental animals. With the 
progress in biotechnology the utilization of isolated heart 
myocytes in biochemical and electrophysiological study 
is rising (de Leiris, Harding, Pestre, 1984; Davie et al., 
2004). Regularly cardiomyocytes are separated from 
cultured embryonic cells or grown-up cells by various 
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techniques (Yu, Rodrigues, McNeill, 1997) for example, 
a langendroff perfusion strategy and enzymatic processing 
technique. Enzyme, for example, collagen type II, 
proteases and pancreatin are generally utilized compounds 
for digestion technique. Confined myocytes are put 
in a perspex chamber super joined with physiological 
salt solution (PSS), and blown with 95% O2 and 5% 
CO2. Field anodes are utilized for compression of cells 
monitoring by different detectors such as mechanical and 
photodiode cluster edge indicators (Roos, Brady, 1982). 
The Pharmacological intercessions are screened in an 
exact and controlled way. These models offers preferred 
advantages, for example, effortlessness, inexpensive 
miniaturisation, decreases animal use in experiments, 
utilize high-number of replica, quick/high throughput and 
generate reproducible data, enabling easy correlation with 
human diseases; cell models accessible for most tissue 
varieties, cell lines support reproducibility and encourage 
between lab examination (Kumar et al., 2016).
In vivo
Left anterior descending (LAD) coronary artery 
route ligation is most generally utilized surgical strategies 
for intense myocardial necrosis. Necrosis can be initiated 
by ligating distinctive area of the coronary supply route. 
This technique was first presented in 1954 by Johns and 
Olson et al and with couple of alterations, now broadly 
use in both small and large animals (Thomas, Johns, 
1954). Mice and rats are usually utilized in laboratory 
for surgical ligation since they offer a various advantages 
over other rodents and animals (Srikanth et al., 2009). The 
surgical strategy involves a few stages; in short animals are 
anesthetized and lied down in the recumbent position. The 
left half of the sternum is cut horizontally alongside third 
and fourth inters costal muscle. Third and fourth ribs are 
isolated by retractor; heart is uncovered by pressing out 
and LAD coronary supply route is ligated by clean suture. 
Electrocardiography (ECG) is performed to approve the 
procedure; ST-segment height and whitish color of front 
left ventricle wall demonstrates induction of Myocardial 
Infarction. The fundamental confinements of this model 
are high death rate, post-surgical contamination and 
difference in infarct size from 4-59%, necessity of master 
hands and artificial ventilator. Anyhow, this procedure has 
the mortality which was accounted to be over 50% because 
of malign ventricular tachycardia in the preliminary stage. 
Moreover, areas of necrosis are small much of the time 
(averaging 21% of the left ventricle), which is conceivably 
because of a high number of sub-pericardial collaterals in 
this species. Hence, just minor haemodynamic variations 
were observed (Hood, McCarthy, Lown, 1967). In 
addition, the model is tedious, costly and is criticised 
regarding animal protection efforts. Nonetheless, the use 
of this strategy in the pig caused a mortality of just 20%, 
because mainly of intense ventricular tachycardias and 
ventricular fibrillation.
By altering the regular surgical technique, researcher 
overcome the previously mentioned impediments of LAD 
ligation and offer a few advantages, for example, survival 
rate of animals are increased, uniform necrosis size and 
prevent postsurgical disease (Iwanaga et al., 2004).
Left ventricular MI
The draft of left ventricular MI in rats has been 
introduced by Pfeffer et al. (1979). In short, after 
anesthesia, orotracheal intubation and thoracotomy, the 
heart is quickly exteriorised and the LCA is ligated in the 
proximal portion utilizing a thin thread. The blockage of 
the artery can be perceived by whitening of the tissue far 
from the ligation. Rats with areas of localized necrosis 
greater than 46% promotes congestive HF following 
21 days with raised filling pressure, diminished cardiac 
output, and a negligible ability to react to pre-and after-
load pressure. The level of weakness of LV work is 
specifically identified with the degree of myocardial loss 
(Pfeffer et al., 1979). The mortality is by all accounts strain 
reliant. In a comparative report the mortality of Sprague-
Dawley rats was 36%, while in Lewis innate rats it was 
fundamentally lower (16%) (Liu et al., 1997). Now a day 
the mouse is the species progressively used to specify MI 
induced by coronary artery ligation. The surgical method 
to incite MI in the mouse is like the rodent model. Most 
instances of death happen inside 1 h after occlusion, 
presumably because of ventricular fibrillation and extreme 
intense HF (Klocke et al., 2007).
Coronary artery ligation followed by reperfusion
In 1995 Michael et al. initially depicted the open 
chest in vivo mouse model. Like the MI animal models, 
the coronary artery route is occluded with a piece of 
dampened umbilical tape (for large animals) or thread (for 
small rodents), yet a little plastic tube is set between the 
ligated vessel and a hub is used which account for easy 
and safe removal of ligation. Mice are anesthetized with 
phenobarbital (50 mg/kg, i.p.), placed in the recumbent 
position by taping the edges and the upper jaw. From the 
xiphoid process to the submentum a midline skin cut is 
made. After dissecting and isolating the salivary organs, 
the muscles overlying the trachea are withdrawn, and a 
F. Ahsan, T. Mahmood, S. Usmani, P. Bagga, A. Shamim, R. Tiwari, N. Verma
Braz. J. Pharm. Sci. 2020;56:e18365Page 6 / 23
tracheotomy is performed. A polyethylene tube (No. 90) 
is precisely embedded into the trachea (around 5 mm from 
the larynx), taped in place to prevent dislodgement and 
associated by means of a free intersection to a rat ventilator 
(display 687; Harvard Apparatus). After ventilation (tidal 
volume 1,2 mL/min., rate 110 strokes/min.) is started by 
supply of 100 % oxygen the chest is opened by a sidelong 
cut along the left half of the sternum. A sufficient tidal 
volume brings about a satisfactory swelling of the lungs 
without overexpression. The entire procedure is performed 
under a magnifying lens (Olympus SZH 10). By the help of 
electrocoagulator, intercostal artery & veins are coagulated. 
The chest wall is then open utilizing a 6-0 silk suture for 
better analysis of the heart. After removing the pericardial 
sac and then left auricle is slightly drawn back, leading to 
clearly visible of left descending artery (LAD). A 1 mm area 
of a PE-10 tubing is put over the LAD to secure its occlusion 
without harming the LAD. The LAD occlusion is finished 
with a 8-0 silk and ends up noticeably clear by staining of 
the left ventricle. The last end of the suture is expressed 
through each side of the chest wall, the chest is shut at last, 
the suture ends are tucked under the skin. 
To prevent cooling of the animal, it is essential 
to utilize a warming cushion set under the mouse 
(Michael et al., 1995). At the time of ligation, the chest 
cut is secured with saturated dressing gauze to prevent 
drying and loss of heat (Vandervelde et al., 2006). After 
a specified time of LAD ligation, the occlusion can be 
evacuated by cutting the bunch over this PE-10 tube 
and reperfusion can be confirmed by visual evaluation. 
Ischemia can be identified by the sudden region based 
whiteness of the myocardium and ECG changes. 
Reperfusion is confirmed by the presence of hyperaemia in 
the previous white area. The total time period of coronary 
artery ligation is vital for the pathophysiological result: 
With increasing time of ligation the hazard for necrosis 
of the staggered myocardium increases.
Minimal invasive ischaemia/reperfusion model
The advantage of this in vivo model demonstrate 
with an implantable device for artery ligation is to beat the 
abnormal level of inflammation because of surgical injury 
related with the open chest model, allowing a more exact 
and interpretable reaction about the inclusion of various 
cytokines and other sources in the ischaemia/reperfusion 
damage of the myocardium (Lee et al., 1971).
After performing out a thoracotomy as portrayed 
in the open chest model, a 8-0 Surgipro monofilament 
polypropylene suture is passed under the LAD with the 
help of U-shaped tapered needle. The two edges of the 
suture are strung through a 0.5 mm bit of PE-10 tubing, 
shaping a free catch around the LAD, and are then strung 
through the end of a size 3 Kalt suture needle (Fine Science 
Tools) and extended through both side of the wall of chest. 
The chest is shut, and the blunt ends of the exteriorised 
8-0 suture are then tucked under the skin. The rodent is 
expelled from the respirator and is permitted to inhale 
100 % O2 through a nasal cone until complete state of 
consciousness.
Ischaemia/reperfusion with ischaemic 
preconditioning
Mill et al. have been among the principal researcher 
who exhibited the early period of ischaemic preconditioning 
in the myocardium in the in vivo mouse display. Likewise, 
it has been seen that scientist have utilized this concept 
and demonstrated its exceedingly viability in initiating a 
significant confinement of the myocardial injury. An 8-0 
silk suture with a U-moulded needle is passed under the 
LAD after dissecting the pericardium. The LAD ligation 
ends up by apparently changing the colour to white of the 
left ventricle. For the preconditioning procedure over the 
1 mm plastic tube the knot is fix carefully and loosen after 
the given time. During this process care should be taken that 
there must be no harm to LAD (Miller, Van Winkle, 1999).
For preconditioning, the mouse is allowed to pass 
through three cycles of 5 min. Artery blockage followed 
by 5 min. reperfusion, individually. After ten minutes, the 
animal is passed through 30 min. of coronary ligation of the 
artery, followed by 2 hr of reperfusion. By this method it is 
conceivable to exhibit a reduction of the infarct size around 
50 %. The mechanism behind it is as yet not completely 
illustrated. Different pathways have just been depicted. 
Among the most vital reason behind it, is believed to be 
reactive oxygen species, isoforms of protein kinase C (PKC) 
and adenosine (Conci, Pachinger, Metzler, 2006).
Electrical method
The rats were anesthetized with the help of ether and 
placed on an analyzation board, and a 3-cm longitudinal 
incision is made in the thorax, 2 cm to one side of the 
midline. The heart is uncovered by subperiosteal resection 
of the fourth and fifth ribs. On the surface of wall of left 
ventricle several burns are made by smoothly applying 
a 2-mm-tipped binding iron (Wahl Iso-Tip, Clipper Co., 
Sterling, Ill.) to the epicardium. The affected region is 
roughly 2-4 mm in measurement. The entry points are 
shut by stapling together the muscle and after that the 
skin. The whole task (opening, searing, and shutting) must 
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be finished in less than 2 mm. The rodent is then put in 
a cage where it can be seen easily while recovering. No 
debilitation or change in behaviour is seen in these rats, if 
any change is observed while recovering then it should be 
noted down (Adler, Camin, Shulkin, 1976).
Coronary artery embolisations
Another  l a rge  an imal  model  o f  i schemic 
cardiomyopathy is based on intracoronary embolisations 
with microspheres, agarose or polystyrene beads or the 
intracoronary injection of thrombin and autogenous 
blood with fibrinogen. In the approach developed by 
Sabbah et al. closed chest dogs undergo 3 to 9 catheter-
mediated intracoronary embolisations performed 1–3 
weeks apart. Embolisations are discontinued when the left 
ventricular (LV) ejection fraction is less than 35%. In this 
model the LV end-diastolic pressure (LVEDP) increases, 
accompanied by a significant raise of pulmonary artery 
wedge pressure and systemic vascular resistance. At 3 
months after the last embolisation, the animals exhibit 
patchy myocardial fibrosis and LV hypertrophy, as well 
as increased plasma levels of atrial natriuretic peptide 
(ANP) and norepinephrine (Sabbah et al., 1991). The 
number of β-AR and L-type calcium channels decrease 
and the activity and protein levels of SR Ca2+-ATPase 
drops (Gengo et al., 1992). Coronary artery embolisations 
are induced percutaneously. Therefore, the risk of 
severe inflammatory complications following surgical 
interventions like thoracotomies is reduced. Moreover, 
this model resembles the clinical situation in patients with 
HF and acute coronary syndrome due to embolisation of 
atherosclerotic and thrombotic debris into the coronary 
microcirculation as well as the situation of patients with 
diffuse coronary artery disease such as in diabetes.
There is a limitation of the embolization technique 
stated that the exact location and length of coronary artery 
blockage is to be controlled.
Therefore, Reffelmann et al. (2004) designed a 
new method recently in which a negligible invasive way 
to induce chronic myocardial areas of localized necrosis 
in pigs: An adaptable body containing an open-cell froth 
sponge is percutaneously placed by means of a guide 
wire at a specific position in the coronary artery. Thus, the 
subsequent period in this investigation was just a single 
week and thus the safety and success of this strategy is 
to be proven by observing for a long interval of time 
(Reffelmann et al., 2004).
Hydraulic occluder and ameroid constrictor
These methods are especially used in larger animals 
(e.g. pig) allowing for the complete or partial occlusion of 
coronary artery branches. Accordingly, they are suitable 
to induce MI and HF (Harada et al., 1994; Roth et al., 
1987), as well as coronary stenosis for the investigation 
of hibernating myocardium. For occluder implantation a 
left anterolateral thoracotomy is performed. After incision 
of the pericardium, a branch of the left coronary artery 
(LCA) is dissected and the hydraulic occluder is placed 
around the vessel. It is then inflated to induce partial 
stenosis or complete occlusion. To control the degree of 
occlusion and record the downstream flow through the 
LCA, an ultrasonic flow probe can be placed distally to the 
occluder during the same procedure (St Louis et al., 2000). 
An ameroid constrictor is implanted in a similar way but 
occlusion is achieved by a different mechanism. At body 
temperature, the ring around the vessel narrows gradually 
because of the hygroscopic property of the casein plastic 
material. As the hydraulic occluder the ameroid constrictor 
allows for the generation of big animal models for the 
investigation of MI-induced HF (Harada et al., 1994; 
Roth et al., 1987). 
Rat aortic banding
Suprarenal aortic coarctation causes a short 
receptive hyperreninemia which last for less than 4 days. 
After that, the moving renin– angiotensin framework is 
not activated, yet the ventricular ACE movement starts 
to rise. As the time passes for several weeks, ventricular 
ACE movement may diminish again to ordinary esteems 
which might be identified with standardization of stress of 
coronary wall with expanding hypertrophy (Holtz et al., 
1992). Various investigations have been performed 
utilizing aortic banding in rats to assess diverse parts 
of left ventricular hypertrophy. After several months, 
a failure is observed in a subset of animal. In a current 
report, interminable exploratory aortic tightening caused 
by banding of the ascending aorta in weanlings brought 
about repaid left ventricular hypertrophy of the grown-
up rats for half a month. Following 20 weeks of aortic 
banding two different groups could be distinguished: rats 
without change in development of LV systolic pressure 
and those with a high reduction in LV systolic pressure. 
The group with high reduction showed expanded left 
ventricular volumes, decreased ejection fraction and 
clinical indications of plain heart failure. Increase in size 
of left myocardium and failure was related with expanded 
β-myosin heavy chain mRNA and atrial natriuretic factor 
mRNA. Meanwhile, after 20 weeks of banding the level 
of SR-Ca2+-ATPase mRNA levels starts decreasing due to 
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polymerase chain reaction which occurs in failing animals 
but not in nonfailing hypertrophied rat hearts.
From this information, it was proposed that the 
decline in SR-Ca2+-ATPase mRNA levels might be a 
indicator of the change from compensatory hypertrophy 
failure in animals (Feldman et al., 1993). During repaid 
hypertrophy, while catecholamine levels are in normal 
level, there is stimulation of the local myocardial renin– 
angiotensin framework, which might be imperative for the 
advancement of myocardial failure. Plasma catecholamine 
levels can be increased with the development of heart 
failure (Hasenfuss, 1998).
Cryogenic injury
Cryogenic damage is another mouse model for 
contemplating heart recovery and cell re-modelling. Same 
as that of MI, the cryoinjury model show incites confluent 
injury however it does not leave extra cell in the centre of 
the inury. It can likewise have interdigitating suitable and 
injured tissue (Murry et al., 1996).
Research shows that cardiomyocytes have capability 
to multiply adequately to effectuate myocardial recovery 
after broad cryoinjury of the LV myocardium in grown-
up mice. Large amounts of macrophages moves and 
matches with the most high amounts of cardiomyocyte 
multiplication, recommending a beneficial role of these 
cells in myocardial recovery (van Amerongen et al., 
2008). Cryogenic damage can be incited at various places 
all through the heart, depending upon researcher’s area 
of interest. An open thoracotomy approach is utilized 
to prompt cryoinjury on the LV, because the freezing 
procedure can be directly visualized and quick validation 
of the subsequent frosting damage. A liquid nitrogen-
cooled aluminium probe is connected specifically onto 
the front LV for ~10 seconds. The solidified myocardium 
defrosts totally 10-15 seconds following probe evacuation, 
and the damaged zone displays a dark red colour (Robey, 
Murry, 2008).
Another approach is through a stomach incision to 
prompt cryoinjury on the right ventricle (RV). Mice are 
anesthetized and the midriff is opened through a transverse 
laparotomy. The translucent stomach is uncovered by 
lifting the chest with a divaricator. The surface of the heart 
is presently noticeable through the stomach and the region 
in which damage is to be done is selected. A blunted tip 
stainless steel Von Graefe snare is specifically set on the 
stomach subsequent to cooling for ~2 min in fluid nitrogen 
to make an apical or midventricular RV damage. Two 
successive 10-s exposures (with an irregular 30-s inteval) 
cause a broad, transmural sore on the lateroapical part of 
the RV wall with an ex-pressure to the apical LV wall. A 
single 30-s exposure causes a broad, transmural lesion on 
the midventricular RV wall with no ex-strain to the septum 
(Grisel et al., 2008).
Genetically Modified Mice: With the improvement 
of hereditarily changed mice, the scientific comprehension 
of disease components and procedures has extraordinarily 
advancement in the field. These advantages would 
have been extensively delayed utilizing entirely in 
vitro research assay. Atherosclerosis is the key factor in 
charge of progression and precipitation of ischemic heart 
disease. In wild mouse acceptance and improvement of 
atherosclerotic model is common. This confinement can 
be reduced by accessibility of knockout and transgenic 
mouse models. 
These  animal  models  add to  a  more  deep 
comprehension of the science of atherosclerosis and 
empower new instruments and pharmacological 
examinations to enhance current treatment of myocardial 
necrotic tissue (Hasty et al., 2001).
a)  Knockout Mouse Model: This is a genetically 
modified model of mouse in which a specific gene is 
targeted and is “knocked out”. Thus the gene which 
has been knocked out loses its activity and this leads 
to change in the phenotypes of mouse. When the 
genes of low-density lipoprotein receptor (LDLR 
gene) is removed it results in LDLR-deficient mice 
(LDLR-/- mice) while the removal of APO lipopro-
tein E (ApoE gene) leads to ApoE-deficient mice 
(ApoE−/− mice). Removal of COX-1 and 2 genes, 
leads to development of COX-1 and 2 deficient mice 
and these mice plays a major role in screening of 
antiplatelet drugs.
(i) LDLR−/− Mice: The LDLR−/− mouse resemble 
a animal model of common hypercholesterolemia because 
of mutation which affect the LDLR, while the lipoprotein 
found in plasma resembles that of human. ApoB and 
ApoE contain lipoproteins and a major role is played by 
LDL receptor in the clearance of the same containing 
lipoproteins. These mice are hereditary deficient in low 
density lipoprotein receptor (LDLR). This deficiency 
leads to various phenotypic changes such as change in 
lipoprotein metabolism, rise in high cholesterol level 
which is same as that of hypercholesterolemia of humans. 
Symptoms like rise in plasma cholesterol level, slow 
clearance in VLDL and HDL from atherosclerotic wound 
and plasma on coronary arteries are seen in mice after 
feeding a normal chow diet. Earlier research report suggest 
that LDLR−/− mice when feeded on regular chow diet 
A conglomeration of preclinical models related to myocardial infarction
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show medium lipid levels and develops very less amount 
of atherosclerosis, but when the same diet is feeded for 
around 8 month, then drastic rise in cholesterol level with 
some marked wound near aorta. Thus we can conclude it 
as the grade of hypercholesterolemia and atherosclerotic 
sore in LDLR−/− mice can be increased by administering 
a high fat diet, a high cholesterol diet (Bentzon, Falk, 
2010), by using mutagens for apoB genes for permanent 
removal (Véniant et al., 1998) and by crossing with 
leptin-deficient mice (Hasty et al., 2001) or with apoB100 
transgenic mice (Sanan et al., 1998). But the response 
shown after treatment with hypolipidemic drugs differs in 
both LDLR−/− and LDLR−/−apoE−/− mice and varies 
from reduction of plasma cholesterol or without reducing 
plasma cholesterol without decrease in atherosclerosis 
(Zadelaar et al., 2007). Some scientist found that when 
LDLR−/− mouse are treated with agonists of peroxisome 
proliferator-activated receptor (PPAR) or liver X receptor 
(Li et al., 2000) shows a huge fluctuation in response, and 
stated that this model can’t be a standard for screening of 
anti hyperlipidaemic drugs (Plump et al., 1992).
(ii) ApoE−/− Mice: Apo E gene plays an important 
role in the management of lipid metabolism and 
development of atherosclerosis. ApoE−/−mice were first 
generated in 1992 by knocking out ApoE gene resulting in 
a huge rise in the plasma level of LDL and VLDL because 
of the clearance through the LDLR and LDLR-related 
proteins stating the same pathophysiological growth of 
atherosclerotic sore as humans (Hu et al., 2005). The 
VLDL particles are the main lipoprotein in ApoE−/− mice 
which plays a crucial role in stimulating atherogenesis 
in this animal model. Female mice are more susceptible 
to atherosclerotic injury and the most common site for 
injury are aortic root, aortic band followed by left coronary 
arteries. The ApoE−/− mice are usually cross breeded with 
other transgenic mice in order to understand the response 
of other genes on development of atherosclerotic plaque. 
The anti-atherosclerotic activity of Statins, a prominent 
antilipidemic drugs have been successfully done by using 
ApoE−/− mice.
Furthermore, the apoE−/−mouse serves as an 
important tool to: 
(i)  Identify and specify atherosclerosis sensitive-caus-
ing genes, by the candidate-gene and gene-mapping 
methods, 
(ii)  Analysing various molecular mechanism and types 
of cell involved in atherogenesis, 
(iii)  Find out effect of drugs on atherosclerosis, and 
(iv)  Identify and discover novel therapies that prevent 
injury progression.
The apoE−/−mice are now a days the most 
commonly utilized animal model for the screening of 
atherosclerosis. In fact, the response of large number of 
genes on the progress of atherosclerosis has been identified 
by cross over the apoE−/− mice with other genetically 
altered rodents (Zaragoza et al., 2011).
b)  Transgenic Mice: Transgenic methodologies 
have provided a large series of very fruitful 
model of mouse for the study of atherosclerosis 
and hyperlipidemia. Among all these, ApoE mice 
resulted after mutation such as apoE3Leiden (E3L) 
and apoE (Arg 112→Cys→142) crossed mice, are 
more commonly used for the study. These mice 
shows a lipoprotein profile which can be compared 
to that of patient with dysbetalipoproteinemia, 
in which total plasma and cholesterol level are 
restricted to VLDL (Hofker, van Vlijmen, Havekes, 
1998). The E3L genetically altered mice develops 
atherosclerosis injury with the same symptom of 
human vasculopathy, thus varying from thick to mild 
and to narrow plaque formation (Leppänen et al., 
1998). Furthermore, E3L genetically altered mice 
and recently the most crossed E3L/Cholesteryl 
ester transfer protein (CETP) transgenic mice have 
been showing more sensitivity to a large number of 
antihyperlipidemic drugs and PPAR agonists than 
apoE−/− and LDLR−/− mice (Van Der Hoorn et al., 
2009). Advantages and disadvantages of various 
myocardial infarction models has been outlined. 
(Table I).
Chemical methods
Chemotherapy with certain cytotoxic medications is 
related with serious symptoms, for example, cardiotoxicity. 
As these symptoms can be dose dependent and cause 
extreme morbidity and even mortality. Getting knowledge 
about their chance and mechanism of occurrence of side 
effect is imperative. Cardiotoxicity can happen as intense 
or as long term adverse effect. With expanding survival 
rates, now a day’s scientists are focussing to avoid the late 
onset of diseases and its severe effect.
Anthracyclines, for example, doxorubicin and 
epirubicin are known for their cardiotoxic adverse 
effect and extensive research is done to investigate the 
component of anthracycline mediated cardiotoxicity. Other 
cytotoxic medications that have shown cardiotoxicity 
are 5-fluorouracil, cisplatin, paclitaxel and docetaxel 
and some latest drug such as, monoclonal antibody 
trastuzumab. Till date the most common speculation for 
this type of side effect or toxicity is alleged as 'free radical' 
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TABLE I - Advantages and disadvantages of various myocardial infarction models
Methods Models Clinical Advantage Clinical Limitation
In vitro
Coronary artery ligation in 
isolated working rat heart
•	 It allows the consctruction of cardiac function curve 
under various conditions. 
•	 Irriversible damage occurs after shorter period of 
ischemia; all neurogenic and hormonal influences 
are removed.
•	 Complicated process.
•	 Chance of tissue death is maximum.
•	 Exact position of coronary artery ligation 
has been not mentioned in literature. 
Coronary artery ligation 
followed by reperfusion
•	 Perfusion fluid volume and content are easily 
controlled
•	 Metabolic substrates are conserved because only a 
small amount of tissue is being perfused.
•	 Decreases the variation in infarct size following 
surgery
•	 Decrease the incidence of excessive bleeding during 
the operation.
•	 Invasive and 
•	 Time consuming approach
•	 Results in extensive tissue damage and 
high mortality
Langendorff Heart Model •	 Elimination of hemodynamic neurohumoral 
hindrances.
•	 Easy to understand the pathophysiological changes. 
•	 Well controlled environmental conditions
•	 Best model for research in mammalian heart 
physiology and biology.
•	 Stability of the preparation.
•	 Do not enable the study of integrated 
response in the complete organism.
In vitro models -Isolated 
Cardiac Cells
•	 It permits works with homogeneous cell population. 
•	 effortlessness 
•	 Inexpensive miniaturisation 
•	 Decreases animal use in experiments 
•	 Utilize high-number of replica 
•	 Quick/high throughput and generate reproducible 
data.
•	 Enabling easy correlation with human diseases.
•	 It usually cut off from the other types of 
cell.
•	 Resemblance to human varies to greater 
extent.
In vivo
Left ventricular MI •	 Mimics same physiological changes as compared to 
human.
•	 Tedious process.
•	 Skill hand required.
Coronary artery ligation 
followed by reperfusion
•	 This new model allows assessment of area at risk 
(AAR), Ischemia size (IS), cardiac function, and 
pathophysiology in the mouse.
•	 Increased surgical  morta l i ty  and 
morbidity.
•	 Increased animal pain and distress.





•	 Reduction of the abnormal level of inflammation 
which occurs in previous model.
•	 Blood loss is reduced.
•	 High survival rate.
•	 Low reproducibility of infarct




•	 Early phase protection.
•	 Performed before the onset of prolonged myocardial 
ischaemia.
•	 Highly effective tool to reduce lethal myocardial I/R 
injury. 
•	 No significant effect on limiting the 
degree of contractile dysfunction. 
•	 Restricted to various cardiovascular 
surgical procedures
Electrical method •	 Size of infarction can be controlled.
•	 Infarction can be done at a targeted place.
•	 Special device required.
•	 Requires skilled person. 
Coronary artery 
embolisations
•	 Resembles the clinical situation in patients with HF 
and acute coronary syndrome due to embolisation 
of atherosclerotic and thrombotic debris into the 
coronary microcirculation as well as the situation of 
patients with diffuse coronary artery disease such as 
in diabetes.
•	 Control of the exact location and length of coronary 
artery occlusion
•	 E x a c t  L o c a t i o n  o f  i n f a r c t i o n  i s 
unpredictable.
•	 Reproducibility of infarction varies very 
much
A conglomeration of preclinical models related to myocardial infarction
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Methods Models Clinical Advantage Clinical Limitation
In vivo
Hydraulic occluder and 
ameroid constrictor
•	 More controlled shunt closure
•	 Its availability in various sizes to accommodate the 
anatomy and size of the vessel to be constricted
•	 The surgery is a relatively simple procedure 
•	 The post-operative monitoring is minimal, since 
there are no external devices to maintain. 
•	 Variability in the rate of occlusion 
•	 Ameroid placement causes mechanical 
trauma, inflammation, fibrosis, and 
thrombus formation.
Rat aortic banding •	 Easy to perform
•	 High success rate in generating cardiac ischeimia in 
a short time
•	 Gradual onset of pressure overload on the heart
•	 Long time process.
•	 This model does not mimic a clinical 
condition.
•	 Maintenance cost of experimental rats is 
therefore also higher.
Cryogenic injury •	 The lesion is highly reproducible in size, location 
and pathophysiological processes 
•	 Very sophisticated process
LDLR−/− Mice •	 show moderate lipid levels and develop no or only 
mild atherosclerosis when fed a regular chow diet
•	 Significant lesion development requires 
the feeding of an atherogenic diet 
containing high fat with or without 
cholesterol.
ApoE−/− Mice •	 Complex vascular lesions readily develop in animals 
fed the normal low fat rodent chow, even when 
plasma cholesterol levels are between 300–500 mg/
dl. 
•	 These lesions are comparable to human lesions. 
•	 Plasma cholesterol is mostly carried on 
lipoprotein remnants rather than the LDL, 
affecting macrophage biology, immune 
function and adipose tissue biology.
Transgenic Mice •	 Contain extra genetic material integrated into the 
genome in every cell.
•	 Generated to carry cloned oncogenes provide good 
model for human cancer
•	 Good models  for  muscle growth study by 
overexpressing the transgene insulin-like Growth 
factor in differentiated muscle fibers. 
•	 Transgene integration is apparently 
random 
•	 Many experiments reveal that the genetic 
surrounding of the inserted transgenic 
construct is modulating the expression 
pattern of the transgene itself both 
qualitatively and quantitatively. 
•	 Transgenic rescue of knockout mice is 
time- consuming, expensive and labour 
intensive. 
Chemical Induced •	 Easy to perform, High Sensitivity •	 High dose required, 
•	 No chemical model is less than a week, 
best result is obtained in around 28 days 
model
TABLE I - Advantages and disadvantages of various myocardial infarction models (cont,)
hypothesis. However, defensive measures following this 
hypothesis, for example, such as administration of free 
radical scavengers have not gave off an impression of 
being clinically effective. The cancer prevention agent and 
iron chelator dexrazoxane has been effectively connected 
to shield the myocardium from cardiotoxicity with high 
dosage anthracycline treatment, but one has to be known 
that complete abolishment of cardiotoxicity can't not be 
accomplished (Schimmel et al., 2004).
Catecholamines are the key mediator of myocardial 
contraction and metabolism. The pathogenesis of the 
catecholamine-induced myocardial injury depends upon 
large number of factors; catecholamines play an important 
part in cardiac physiology. While catecholamines have 
been utilized successfully in clinical pharmacology 
for the treatment of pump disorder, over discharge or 
administration of catecholamines more than normal 
physiological dosages may drain or break the stored 
energy of heart muscle cells that prompts complex 
biochemical and resulting various structural changes that 
proceed from reversibility, called likewise degeneration 
irreversibly onto necrosis. 
Cardiotoxicity incorporates an extensive range of 
heart impacts starting from little changes in blood pressure 
followed by arrhythmias to cardiomyopathy. Literature 
supports various different mechanism of chemotherapy 
causing cardiotoxicity are hypothesized including cardiac 
cell damage due to generation of free oxygen radicals and 
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the initiation of immunogenic responses due presence of 
antigen carrying cells in the heart (Lipp, 1991).
Isoprenaline
Isoprenaline was first used by George Rona to 
produce a infarct in rats (Rona, Kahn, 1969). It is a 
synthetic catecholamine and a potential β-adrenergic 
agonist, caused severe stress on the myocardium resulting 
in infarction like injury of the cardiac muscles and finally 
precipitating MI when administered in large dose. Various 
mechanism of ISO are postulated in causing myocardial 
infarction that includes hypoxia due to hyperactivity of 
myocardium and fall of pressure in coronary arteries, 
overload of calcium, and removal of high energy 
phosphate as well as production of free radicle because 
of auto oxidation of catecholamine leading to membrane 
peroxidation. The pathophysiological and morphological 
changes in occurring in myocardium after isoprenaline 
administration in rats is same with those changes which 
takes place in humans (Amran et al., 2015).
Aluminium chloride
Aluminium (Al) is comprehensively scattered all 
throughout the environment. It is commonly utilized in 
daily life making its easy exposure to animals and human 
beings. Al sources are obtained from corn, yellow cheddar, 
salt, herbs, spices, tea, beauty care products, and containers. 
It has been accounted for that Al could be collect in all 
tissues of living being, specially in liver, heart, bones 
and cerebrum. This metal disturbs the prooxidant/cell 
reinforcement balance in tissues prompting biochemical and 
physiological dysfunction because generation of excessive 
reactive oxygen species (ROS). When the body is exposed 
to high dose of aluminium it reduces the activity of I, II and 
IV of electron transport chain prompting the debilitation of 
mitochondrial energy production and oxidative damage. 
Oxidative stress may play a critical part in heart and vascular 
abnormalities in various types of cardiovascular diseases. 
The mechanism through which Al produces cardiotoxicity 
impacts might be ascribed to oxidative stress and causing 
disturbance in the intracellular redox framework. The 
exact mechanism of Al mediated toxicity is not yet been 
clear, but some correlates it with prooxidant properties of 
aluminium. With an end goal to enhance our comprehension 
on aluminium toxicity on heart mechanism, scientist 
have assessed the cardioprotective impact of selenium by 
overseeing aluminum chloride (50 mg/kg bw) for 21 days 
to deliver cardiotoxicity (Ghorbel et al., 2017).
Azithromycin
The macrolide antibiotics, when administered both 
in combination and alone with different medicine, may 
once in a while cause cardiotoxicity, for example, delayed 
QT interval and polymorphic ventricular tachycardia. 
Azithromycin, which is a broad range second generation 
macrolide group of antibiotics with negligible side effect 
and a pharmaco-dynamic/pharmacokinetic profile that 
permits simple dose regimens, is now used as a treatment 
of bacterial infection, despite the fact that uncommon 
types of cardiotoxicity has been proposed with the 
azithromycin treatment when compared with other 
macrolide subsidiaries, the instances of cardiovascular 
side effect related with azithromycin have drawn attention 
in recent time. Azithromycin promotes oxidative stress & 
this occurs due to a dis ruption in the antioxidant defence 
system and an increase in the generation/production of 
reactive oxygen species in the cases of infarction. This 
further leads to the changes in the cardiac functions and the 
functions of ion channels, ionic pumps, ion exchangers, 
and inflammatory pro cesses have been suggested to be 
associated with the oxidative stress.
As indicated by the information from the 
adverse impact notice system of FDA (Food and Drug 
Administration), azithromycin related with 20 cases of 
Torsades de pointes have been accounted. Moreover, as 
indicated by the reports of the cohort investigations led 
on the patients who got azithromycin treatment, it was 
accounted for that there had been sudden deaths because 
of ventricular arrhythmia due to irrational azithromycin 
use. In spite of the fact that there are case reports attracting 
attention to the cardiovascular adverse effect related with 
the treatment of azithromycin, there was no exploratory 
investigation assessing cardiotoxicity in simultaneous 
pharmacological dose of azithromycin until Atli et al. 
assessed azithromycin (15 mg/kg and 30mg/kg, for 14 
days) incited cardiotoxicity and they expressed that 
azithromycin in simultaneous pharmacological dose was 
determined to cause adverse effect in relation to plasma 
cardiovascular biomarkers and ECG parameters and 
histopathological examination (Atli et al., 2015).
Bupivacaine
Bupivacaine is a local anesthetic drug which is 
widely used now a day because of long duration of 
action and potency. Unfortunately, bupivacaine causes 
severe cardiotoxicity when accidentally administered 
intravenously. Several serious cases of cardiac arrest have 
been reported with the use of bupivacaine repeatedly. 
A conglomeration of preclinical models related to myocardial infarction
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Bupivacaine has prolonged myocardial sodium channel 
blocking properties because it metabolises from channels 
slowly during diastole when compared to lidocaine which 
binds and degrades fast. Previous research shows that 
lidocaine could replace bupivacaine from its receptor 
and some scientist states this property of lidocaine to be 
used during bupivacaine cardiotoxicity. It reduces the 
availability of fatty acids for β-oxidation in myocardial 
mitochondria by specific inhibition of the enzyme 
systems involved in the carnitine shuttle. The resulting 
loss of energy substrate potentially could contribute to 
the cardiotoxicity observed clinically. Research also states 
that conduction blockade by inhibiting Na2+ channel and 
negative inotropy is also promoted by bupivacaine.
Basically animal study support this theory of 
replacement. Bupivacaine were investigated on a 
spontaneously beating isolated rat heart model for its 
Cardio toxic effects. The report shows that the mixture 
of both bupivacaine and lidocaine (bupivacaine 6 μg/
mL, 21 μM and lidocaine 12 μg/mL, 51 μM) disturbs 
the Intraventricular conduction parameters (prolonging 
QRS interval) to a small amount than bupivacaine (6 
μg/mL, 21 μM)) itself, and this effect has been noted in 
the beginning of perfusion (Křikava et al., 2010). The 
role of mitochondrial KATP channels in lipid rescue of 
bupivacaine-induced cardiotoxicity has been studied 
(Partownavid et al., 2013).
Carbon tetrachloride
Carbon tetrachloride (CCl4), is a clear, colourless, 
volatile, heavy and non-flammable liquid, is a well-known 
ideal compound for causing chemical induced cellular 
toxicity by production of free radicals in various tissue 
tissues (Adaramoye, 2009). The most accepted mechanism 
of CCl4 induced cardiotoxicity is the production of 
free radicals which is a rate limiting process in cellular 
peroxidative damage. This free radical and other related 
oxidative species may cause oxidative stress, which 
produces the major interrelated changes in cellular 
metabolism, thus increasing the level of calcium inside the 
cell. Causes damage to the permeability and transport of 
ions through membrane and also destroy the cell by lipid 
peroxidation. A report suggest that injecting CCl4 (1mL/
kg i.p. for 16 days) to rats may cause damage to heart and 
causes the increase in level of the lactate dehydrogenase 
(LDH) and creatine kinase CK and malondialdehyde 
(MDA) level and reduces the level of antioxidant enzyme 
basically SOD, CAT and GPx level in heart indicating 
that heart can be targeted by CCl4.(Eshaghi et al., 2012) 
Other experiment suggest that CCl4 was when induced 
into the rats (1mL/kg, 5th -8th weeks (twice a week), i.p 
route.) resulted into marked uptake and accumulation of 
CCl4 in the cell, the mechanism behind it was postulated 
as generation of free radical & development of oxidative 
stress in the myocardium (Uttam Paul, 2016).
Chlorpyrifos
Organophosphorus pesticides constitute a vast group 
of pesticides and they are utilized generally to control pest 
in the house, crops and urban condition. Chlorpyrifos 
is a wide range organophosphate pesticides used 
broadly in agribusiness and for controlling pest in house 
throughout the world under various enlisted trademarks. 
Chlorpyrifos, as other organophosphates, shows its toxic 
impacts basically by hindering the activity of enzyme 
acetylcholinesterase. Xenobiotics, including insecticides, 
are known to stimulate the production of receptive oxygen 
species (ROS), which causes oxidative stress in various 
tissues. Chlorpyrifos have different effect on the cell 
including release of reactive oxygen species and enlistment 
of intracellular oxidative pressure in such manner that it 
disturbs the normal cellular structure and multiplication 
of cardiomyocytes. Chlorpyrifos is additionally known 
to create oxidative stress thus causing accumulation of 
lipid peroxidation residue in various organs of rats and 
initiate histopathologic changes in various tissues. Study 
demonstrated that low dosage of chlorpyrifos (5.4 mg/kg 
bw, 4 week) causes cardiac toxicity, chlorpyrifos causes 
major changes in the properties of antioxidant enzymes in 
rats (Baş, Kalender, 2011).
Cisplatin
Cisplatin (Cis-diamminedichloroplatinum) 
is a platinum-conjugated anti-carcinogenic drug 
that is regularly utilized as a part of the treatment 
of solid tumors. The therapeutic impact of CP rises 
noticeably with increasing the dose. Then again, 
the clinical utilization of CP has been constrained 
because of expanded oxidative stress, and symptoms 
(nephrotoxicity, cardiotoxicity) because of apoptosis. 
CP react with DNA, and causes intra- and inter-cross 
linkage. The subsequent DNA produced starts apoptosis. 
Study demonstrated the cardiotoxic response of 
cisplatin may cause electrocardiographic changes, toxic 
effect of free radicals, mitigate the lipid peroxidation 
which was diminished by concentrate of grape seed 
proanthocyanidins (Lian et al., 2016). Expanded 
oxidative stress and histopathological injury have been 
involved in the cardiotoxicity that constrains the clinical 
F. Ahsan, T. Mahmood, S. Usmani, P. Bagga, A. Shamim, R. Tiwari, N. Verma
Braz. J. Pharm. Sci. 2020;56:e18365Page 14 / 23
use of cisplatin (CP) as an anti-cancer drug which was 
then analysed by managing cisplatin administration after 
treatment by hesperidin (Oguzturk et al., 2016).
Clozapine
Clozapine, a tricyclic dibenzodiazepine, is an 
atypical antipsychotic medication that is exceptionally 
viable in treating psychosis, especially in those patients in 
which other drugs are inefficient. It has potent antagonistic 
properties on D4-dopaminergic receptor, serotonergic, 
noradrenergic, histamine and cholinergic M2 receptors. 
But sometimes, some antagonistic impacts of clozapine 
have constrained its clinical importance. A typical and 
common antagonistic impact requires severe monitoring 
of its cardiotoxicity. The mechanism behind clozapine-
mediated cardiotoxicity isn't yet fully comprehended but 
demonstrate a possible IgE-mediated hypersensitivity 
response demonstrated an increase in the level of receptive 
oxygen species (ROS), Certain cytokines, for example, 
tumor necrosis factor-α (TNF-α) in the myocardium, 
clozapine-mediated cardiotoxicity was presented in rats by 
regulating a measurements of 10, 15 and 25 mg/kg/day, i.p. 
for 21 days. It causes genuine and deadly problems during 
the entire clozapine treatment in rats. Increased myocardial 
oxidative stress, cytokines causing inflammation, cell and 
DNA injury and apoptosis with weakening in antioxidant 
defence are largely contributing components. This requires 
a high level of clinical care through the course of clozapine 
treatment. The utilization of echocardiographic (ECG) 
observing as a standard periodical check over the span of 
clozapine treatment, and biohumoral examination if any 
indications of cardiotoxicity begins to appear is suggested 
(Abdel-Wahab, Metwally, 2014).
Cyclophosphamide (CP)
It is broadly utilized as an antineoplastic and 
immunosuppressant medication. It is utilized for the 
treatment of constant and intense leukaemia’s, different 
myeloma, lymphomas, and rheumatic joint inflammation 
and in preparation for bone marrow transplantation. In 
spite of the fact that it has tumor selectivity and wide 
range of clinical uses, CP is known to cause lethality in 
multiple organs. High dosage of CP when administered 
can cause a severe type of cardiotoxicity within 10 days 
which shows as a blend of manifestations and indications 
of myopericarditis prompting lethal complications, 
for example, congestive heart failure, arrhythmias, 
cardiovascular tamponade and myocardial depression. 
Cyclophosphamide quickly disturbs the cellular 
respiration and furthermore harms the internal 
mitochondrial layer of heart prompting the penetrability 
of calcium ion is mediated by oxidative stress. 
Cyclophosphamide initiated cardiotoxicity has been 
involved in increasing the production of superoxide 
radicals and hydrogen peroxide. These receptive oxygen 
species (ROS) injure the heart by surpassing the oxygen 
radical detoxifying limit of cardiovascular mitochondria. 
In this manner, the antioxidant treatment might be helpful 
in the administration of CP incited cardiotoxicity. Latest 
research demonstrates that the CP (200 mg/kg, i.p. single 
measurements) treatment promotes heart weight and 
diminished body weight in rats (Viswanatha et al., 2013). 
Research demonstrates that Cardiotoxicity was showed 
after the rats were administered cyclophosphamide 
(150 mg/kg, i.p.) causing severe blockage, oedema and 
extravasation in the cardiovascular tissues, and in addition 
a specific leucocytic penetration is obtained by visible and 
histopathological examination (Gado et al., 2013).
Doxorubicin (DXR)
It has been demonstrated that doxorubicin (DXR), 
an anthracycline antibiotic having broad spectrum against 
numerous malignancies, has restricted clinical use due to 
its cardiotoxicity. Utilization of DXR brings about changes 
in blood pressure and heart rate and additionally loss of 
contractility. It was exhibited that DXR cardiotoxicity 
brings about interruption of myocyte structure, including 
injury to the microtubules, vacuolization, sarcomere 
disturbance, dilatation of the sarcoplasmic reticulum, 
mitochondrial damage and loss of myofibrils. Oxidative 
injury to membrane lipids and other cellular component 
is sought to be a main consideration in DXR toxicity. 
Doxorubicin causes myocardial injury by means of the 
development of free oxygen radicals. In normal healthy 
conditions free oxygen radicals are effectively detoxified by 
antioxidants enzyme, for example, superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase 
(GSH-Px). In any case, when there is an imbalance 
between the production of oxidants and the particular 
defence frameworks of the organism, the enlistment 
of lipid peroxidation and modification in intracellular 
homeostasis takes place, as observed in DXR-mediated 
cardiotoxicity. Research shows that in rats ultrastructural 
adjustments was actuated by Doxorubicin (10 µmol kg/
day/i.p.) in numerous organelles, including disturbance 
of mitochondrial fine structure (Fadillioglu et al., 2004). 
Other research recommends about doxo mediated dose 
dependent toxicity in which doxo was given alone (6 and 
15 mg/kg) and in combination (Shahzadi et al., 2014).
A conglomeration of preclinical models related to myocardial infarction
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Gamma radiation 
When a body is exposed to radiotherapy, ionizing 
radiation communicates with biological frameworks of 
the body to deliver free radicals or reactive oxygen species 
(ROS), which causes injury to different cellular segment 
including DNA, proteins and membrane lipids, prompting 
chronic cellular injury. ROS likewise negatively affect 
the cell antioxidant protection systems, diminish the 
intracellular accumulation of glutathione (GSH) and 
reduction the efficacy of superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GSHPx) 
(Azab et al., 2011) found that radiation may cause 
the production of ROS that associates with biological 
molecules and producing less toxic free radicals. The 
final yield of peroxidation is malondialdehyde (MDA), 
significant aldehyde compound that is mutagenic in cells 
and could be identified to assess tissue damage. 
Plasma lipids level is increased by day 6 post 
radiation; plasma cholesterol, triglycerides (TG) level were 
increased. Additionally low density lipoprotein (LDL) was 
increased and accumulated in plasma while high-density 
lipoprotein (HDL) level was diminished. The introduction 
of the human body to ionizing radiation causes breakdown 
of endogenous antioxidant and dependable antioxidant 
that can secure tissues against radiation-mediated injury. 
Reports showed symptoms of cardiotoxicity when rats 
were exposed with a solitary measurement level of (10 
Gy) radiation transferred at a dosage rate of 0.46 Gy/min. 
at the time of experiment (Elkady, Mohamed, 2016).
Imatinib
Imatinib, is a best example of small molecule therapy 
drug, and has set a benchmark in the treatment of endless 
myeloid leukaemia (CML), and is currently prescribed as 
standard treatment for the fast growing and chronic stage 
infection, and additionally for the treatment of cutting 
edge gastrointestinal stromal tumors (GIST). Research 
data demonstrates that serious cardiotoxicity of imatinib 
in both a clinical setting and under exploratory conditions 
has been completely documented. It is a tyrosine kinase 
inhibitor (TKI), current TKI drugs distort fundamental 
pathways regulating the mitotic development of tumor 
cells. These same pathways have been distinguished as 
additionally being essential for keeping up the cells alive 
in typical tissues, for example, the heart. Studies stating 
Imb-mediated cardiovascular injuries depict different 
types of morphological changes in myocyte. Imb-mediated 
heart alteration was studied, in which male spontaneously 
hypertensive rats (SHRs) were administered with oral 
dose of 10, 30, or 50 mg/kg Imb or water day by day for 
10 d. Cardiac sores, identified at all doses, were stated by 
cytoplasmic vacuolization and myofibrillar loss. Other 
experiment suggest that , Cardiac injury were identified in 
Sprague Dawley (SD) and SHR rats when administered 50 
or 100 mg/kg Imb for 14 d (Herman et al., 2011).
Lead and Mercury
Heavy metals are a group of natural chemicals 
which possess several toxic effects on living beings. In 
spite of the fact that metals have adverse effect when 
exposed to living organism, their use and importance 
is continuously expanding. Expose to heavy metals has 
been connected to increase the risk of cardiovascular 
problem. Mercury, an outstanding toxic substance, 
causes toxicity through interaction with cell thiols and the 
generation of responsive oxygen species (ROS). These 
ROS incorporate superoxide, hydrogen peroxide and also 
hydroxyl radicals. 
ROS instigate cell dysfunction through oxidative 
injury in membrane lipids and proteins. Lead is an essential 
natural poison that actuates a wide scope of physiological, 
biochemical, and behavioural dysfunctions. It can 
prevent biological functions by altering the molecular 
communications, cell function and cell signalling 
procedures. It influences organs that have low antioxidant 
defence, for example, the heart. Recent investigation 
demonstrated that mercury chloride (0.02 mg/kg b.w 
for 28 days) and lead nitrate (45 mg/kg b.w for 28 days) 
intoxication caused ROS production which incited 
histopathological changes in rat heart (Kalender, 2016).
Lithium
Lithium (Li) is a most widely used and studied long 
term treatment for the effective of bipolar treatment, used 
against both manic episode, depression and reduces the 
chance of committing suicide. Lithium has some clinical 
involvement as a narrow therapeutic index requiring 
routine observation of serum levels; however it is still 
regularly used in spite of various side effects. The most 
well-known alteration appears in the kidney, endocrine 
organs, gastrointestinal tract and in the heart. When Li is 
administered in low dose, electrocardiographic changes 
in patients accepting Li treatment have been reported. 
Li treatment is related with variable electrocardiography 
(ECG) changes including QT prolongation, ST section 
and T wave changes, heart arrhythmias, trio-ventricular 
disturbance and myocardial localized necrosis (MI). 
Likewise, lithium constricts cardiovascular sympathetic 
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re-innervation after MI and Reactive Oxygen Species 
(ROS) are exceeding in ventricular remodelling following 
MI. Study demonstrated that Li (2, 5, or 100 mg of lithium 
chloride/kg, i.p.) aggravated an expanded oxidative 
stress status, proven by high lipoperoxidation and protein 
carbonylation, with a low non protein thiols level and 
influenced antioxidant enzymes as CAT, Gpx and SOD 
(Mezni et al., 2017).
Penconazole
Triazole fungicides are one of the most important 
group of pesticides used in agriculture. The mechanism 
of action behind these fungicides is to inhibit the activity 
of lanosterol 14α demethylase (CYP51), which is a key 
enzyme for biosynthesis of ergosterol in fungi, leading 
to dysfunction of membrane and inhibits the uptake 
of substrate. Penconazole (PEN) (1-(2,4 dichloro-β-
propylphenethyl)-1 H-1,2,4-triazole) is known as the 
active material of a systemic triazole fungicide basically 
used in horticultural, agricultural, and forestry industries 
for harmful pathogen control. This fungicide has shown 
a resistant toward degradation and also gets accumulated 
in soils. Penconazole induced cardioprotection in rats 
demonstrated that PEN (67 mg/kg, i.p. for 7 days) induced 
a state of oxidative stress in the heart of adult rats as proved 
by the increased lipid peroxidation, PCO formation, and 
the changed enzymatic and nonenzymatic antioxidant 
situation. PEN administration also resulted in inhibition 
of the cardiac AChE activity and altering the metabolism 
of lipid. The toxic effects of PEN are basically mediated 
through free radical generation, leading to injury in various 
cardiomyocyte structure (Chaâbane et al., 2016).
Tilmicosin (TIL)
This is a semi-synthetic macrolide antibiotic 
mostly used in veterinary medicine. It is a 16-member 
macrolide which is obtained by chemical mod ification of 
desmycosin. This mechanism behind this antibiotic is to 
bind on the 50S ribosomal subunit thus inhibiting microbial 
protein synthesis. However, this drug has been reported 
to have cardiovascular toxicity in animals. The overdose 
administration causes positive chronotropic and negative 
inotropic cardiovas cular dysfunction with increased 
heart rate and loss of ventricular function, specially in 
young animals. The above effect mainly depends on dose, 
animal species and route of administration. Tilmicosin 
when administered in rats (75 mg/kg, s.c.) induced 
cardiac injury reported by increase of AST, LDH, CK and 
cTnT biomarkers as well as myocardial tissue injury and 
myocytolysis (Fahmy et al., 2013). The administration 
of Tilmicosin results in causing various degree of lipid 
peroxida tion, inhibition in antioxidant enzymes activities 
and changes in serum biochemical parameters of mice 
(Ibrahim, Abdel-Daim, 2015). Summary of chemicals 
TABLE II - Summary of chemicals inducing myocardial infarction along with their mechanism
S.No Chemicals Category Mechanism Dose References
1 Isoprenaline Synthetic 
catecholamine and 
β-adrenergic agonist
•	 Hypoxia due to hyperactivity of myocardium.
•	 Fall of pressure in coronary arteries, overload of 
calcium.
•	 Removal of high energy phosphate as well 
as production of free radicle because of auto 
oxidation of catecholamine leading to membrane 
peroxidation.
85 mg/kg Amran et al., 2015
2 Aluminium Chloride Salt of aluminium 
and chlorine
•	 Oxidative stress 
•	 Disturbance in the intracellular redox framework. 
•	 Prooxidant properties of aluminium
50 mg/kg Ghorbel et al., 
2017
3 Azithromycin Macrolides 
Antibiotics
•	 Oxidative stress occurs due to a dis ruption in the 
antioxidant defense system
•	 An increase in the generation/production of 
reactive oxygen species in the cases of isch emia-
reperfusion. 
•	 The changes in the cardiac functions and the 
functions of ion channels, ionic pumps, ion 
exchangers, con nexin-43 remodeling and 
inflammatory pro cesses have been suggested to 




Atli et al., 2015
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S.No Chemicals Category Mechanism Dose References
4 Bupivacaine Long-acting local 
anaesthetic
•	 Bupivacaine reduces the availability of fatty acids 
for β-oxidation in myocardial mitochondria by 
specific inhibition of the enzyme systems involved 
in the carnitine shuttle. 
•	 The resulting loss of energy substrate potentially 
could contribute to the cardiotoxicity observed 
clinically. 
•	 Conduction blockade by inhibiting Na channel and 
negative inotropy.
6 μg/mL Křikava et al., 
2010
5 Carbon tetrachloride Clear, colourless, 
volatile, heavy and 
nonflammable liquid
•	 Production of free radicals which is a rate limiting 
process in cellular peroxidative damage, causing 
oxidative stress, which produces the major 
interrelated changes in cellular metabolism, thus 
increasing the level of calcium inside the cell.
•	 Causes damage to the permeability and transport 
of ions through membrane and also destroy the cell 
by lipid peroxidation.
1mL/kg Eshaghi et al., 
2012
6 Chlorpyrifos Broad spectrum
organophosphate 
insecticide
•	 Chlorpyrifos has multiple effects on cells including 
generation of reactive oxygen species and 
induction of intracellular oxidative stress thereby 
disrupting normal cellular development and 
differentiation of cell.
5.4 mg/kg Baş, Kalender, 
2011
7 Cisplatin Organometallic 
chemotherapeutic 
drug
•	 Cisplatin reacts with DNA, and causes intra and 
inter crosslinkage. The subsequent DNA produced 
starts apoptosis.
•	 It induces oxidative stress
7.5 mg/kg Oguzturk et al., 
2016
8 Clozapine Antipsychotic drug •	 Possible IgE-mediated hypersensitivity reaction.
•	 Hyper-catecholaminergic states.
•	 An increased release of inflammatory cytokines.









•	 Cyclophosphamide quickly disturbs the cellular 
respiration 
•	 It harms the internal mitochondrial layer of heart 
prompting the penetrability of calcium ion is 
mediated by oxidative stress.
•	 Cyclophosphamide initiated cardiotoxicity has 
been involved in increasing the production of 
superoxide radicals and hydrogen peroxide.
150 mg/kg Gado et al., 2013
10 Doxorubicin Anthracycline 
category anti-cancer 
drug
•	 Doxorubicin causes myocardial injury by means 
of the development of free oxygen radicals. 
•	 Oxidative injury to membrane lipids and other 
cellular component, injury to the microtubules, 




Shahzadi et al., 
2014




•	 Biological frameworks of the body to deliver 
free radicals or reactive oxygen species (ROS), 
which causes injury to different cellular segment 
including DNA, proteins and membrane lipids, 
prompting chronic cellular injury.
10 Gy 
delivered at
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S.No Chemicals Category Mechanism Dose References
12 Imatinib Tyrosine kinase 
inhibitor based 
anti-cancer drug.
•	 Mitochondrial abnormalities and accumulation of 
membrane whorls. Autophagy.
•	 Cell death in H9c2 cardiac muscle cell.
•	 The cardiotoxic actions of Imb are thought to be 
mediated through suppression of fusion protein 
BCR-ABL activity.





Herman et al., 
2011
13 Lead and Mercury Heavy metals •	 It is related to be enhanced ROS and oxidative 
stress in heart tissue, leading to biochemical 






14 Lithium Mood stabilizer 
metal, Antimanic
•	 Li may directly or indirectly induce oxidative 
stress through the mitochondria via redox cycling, 
or promoting iron accumulation and oxidative/
nitrative modifications of essential mitochondrial 
proteins.
2, 5, or 
100 mg/kg
Mezni et al., 2017
15 Penconazole Systemic fungicide •	 It induced a state of oxidative stress in the heart 
of adult rats as proved by the increased lipid 
peroxidation, PCO formation, and the changed 
enzymatic and nonenzymatic antioxidant situation. 
•	 Its administration also resulted in inhibition of the 
cardiac AChE activity and altering the metabolism 
of lipid. 
•	 The toxic effects of PEN are basically mediated 
through free radical generation, leading to injury 
in various cardiomyocyte structure.
67 mg/kg Chaâbane et al., 
2016
16 Tilmicosin Macrolide antibiotic •	 TMC causes positive chronotropic and negative 
inotropic cardiovas cular dysfunction with 
increased heart rate and loss of ventricular function 
results in causing various degree of lipid peroxida-
tion, inhibition in antioxidant enzymes activities 
and changes in serum biochemical parameters.
75 mg/kg Ibrahim, Abdel-
Daim, 2015
TABLE II - Summary of chemicals inducing myocardial infarction along with their mechanism (cont.)
causing myocardial infarction along with their mechanism 
has been mentioned (Table II).
DISCUSSION
As a result of the epidemiological and financial 
factor of CHD-related MI extensive endeavours to reduce 
this illness are required. Since the comprehension of exact 
mechanism of disease is fundamental necessities to create 
proficient treatments the utilization of animal models is 
vital. In any case, each animal model has preferences and 
particular impediments and none of them is reasonable 
to ponder all parts of CHD-related MI. Before, an 
expansive number of studies have been performed in 
animals with unmistakable clinical heart problem to 
assess pathophysiology from the level of the unblemished 
instrumented animals to the tissue homogenate. These 
sorts of studies expedited a ton of data hemodynamic, 
neurohumoral enactment, myocardial capacity and 
subcellular and sub-atomic changes in the fizzling heart. 
In relation to the previously mentioned animal 
models, it is evident that every animal model assumes 
a critical part in better comprehension of ischemic 
heart disease. The most recent couple of decades have 
seen generous headway in the treatment of ischemic 
heart illnesses because of expanding information of the 
molecular mechanism required amid ischemia/reperfusion 
damage. The major difference between heart size and 
unpredictability amongst laboratory animal and people 
confine the immediate interpretation of the trial results 
to the clinics. Model and species properties decide the 
attributes of the disorder. A helpful model ought to in 
A conglomeration of preclinical models related to myocardial infarction
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any event be of technical significance, in this manner 
permitting potential therapeutic evaluation. Nonetheless, 
none of the accessible models precisely reiterates the 
unpredictable and dynamic pathology that describes 
human MI. 
In any case, it is excessively straightforward, making 
it impossible to contend that the absence of dependable 
models for preclinical testing undermines examinations 
in clinical trials. A specific and accurate model ought 
to be picked in the wake of viewing the question to be 
replied. Better clinical MI stratification and distinguishing 
proof of activating natural factors will additionally build 
the interest for specific models. The requirement for 
accurate model stages and for the advancement of focused 
therapeutic mediations will develop with our insight on MI 
etiology and stratification. 
Small animal models are generally utilized as a part 
of cardiovascular research due to their numerous points 
of interest over large animal models. They have a short 
life expectancy, enabling the researcher to take after the 
characteristic history of the disease at a rapid pace. Large 
animal models are the nearest models of human ailment 
yet they are not reasonable for high output studies. For 
result designed for clinical interpretation, it is basic that 
underlying outcomes from rat thinks about be affirmed in 
a large animal models as they more closely resembles the 
human heart. While picking a large animal model, we have 
to think about the anatomical and physiological contrasts 
between species. 
Additionally, the improvement of genetically 
modified models takes into account quick foundation 
of verification of-principle that can later be investigated 
out into bigger animal models. Notwithstanding, 
rodents have a couple of disadvantages too. They are 
phylogenetically quite dissimilar from human and some 
patho-physiological highlights of diseases and their 
reaction to pharmacological medications may not be 
dependable indicators for humans. Now a days, transgenic 
animal models of hypertrophy and myocardial infarction 
are basically essential for understanding the molecular 
modifications behind the development of the disease. 
Addition or substitution of genes in transgenic mice 
together with scaled down physiological methods to 
assess the subsequent cardiovascular phenotypes permit 
the distinguishing proof of qualities that are causative 
for heart diseases and to assess molecular mechanism in 
charge of the improvement and movement of the disease. 
Notwithstanding, we should recollect that these 
various animal models are a long way from resembling 
to coronary illness in people. Most models include the 
counterfeit reproduction of disease in those tissues 
which were earlier healthy, which varies enormously 
from the intricate and dynamic improvement of human 
cardiovascular sickness. Huge degrees of disparity in 
animal species, contrast to human life structures, small 
heart size and heart estimate and the trouble to extrapolate 
the discoveries to clinical settings are prime bottleneck of 
creature models that keep the pharmacological mediations 
from being incorporated into the general public. In 
the meantime, it is likewise critical to underline the 
significance of the refinement, decrease and substitution 
in animal research. At last animal models hold incredible 
significance in investigating novel mechanism, discoveries 
of new mediations, both pharmacological and surgical 
which can be clinically translated in human.
CONCLUSION
In view of the epidemiological and financial status 
of patient CHD-related HF a great determination to fight 
against this disorder are required. Currently, the most 
commonly used animal in myocardial models are the rat 
and mouse. The mouse specifically has the positive side 
of offering various transgenic and genetically-focused 
strains. However, large animal models have the benefit 
of a high level of physiological similarities to human 
and the less and can be easily applied in the complex 
technical changes. As the cardiovascular disorder has a 
complex nature, no animal model or species can be used 
to exactly reproduce the same disorder as that of human; 
in this manner, proper animal model selection is required 
which has maximum simulation toward the human disease. 
Apart from human similarity, certain other points are to 
be considered: contemplations of cost, framework and 
the necessity for specialized hand. Bringing these points 
into account, scientist must choose the model that best 
imitates the part of disease being examined. In specific, 
while moving from bottom to top it is important to test 
methods in that yield profoundly reproducible outcomes, 
yet in spite of these impediments, a proper strategies 
should be made in order to reduce the chances of error in 
results, and animal models remain the best apparatuses 
for identifying the effect of various molecules/ drugs in 
various myocardial diseases.
ACKNOWLEDGMENT
Author sincerely pays his heartfelt respect 
and gratitude toward Prof. Syed Waseem Akhtar, 
Hon. Chancellor and Prof. M.K.J Siddiqui, Hon. 
Vice Chancellor, Integral University for providing an 
excellent research environment. The University has 
F. Ahsan, T. Mahmood, S. Usmani, P. Bagga, A. Shamim, R. Tiwari, N. Verma
Braz. J. Pharm. Sci. 2020;56:e18365Page 20 / 23
provided a manuscript communication number for further 
communication (IU/R&D/2018-000348).
CONFLICT OF INTEREST
There is no conflict of interest among the authors.
REFERENCES
Abdel-Wahab BA, Metwally ME. Clozapine-induced 
cardiotoxicity in rats: Involvement of tumour necrosis factor 
alpha, NF-κβ and caspase-3. Toxicol Reports. 2014;1:1213-23. 
Adaramoye O. Comparative effects of vitamin E and kolaviron 
(a biflavonoid from Garcinia kola) on carbon tetrachloride-
induced renal oxidative damage in mice. Pakistan J Biol Sci. 
2009;12(16):1146-51.
Adler N, Camin LL, Shulkin P. Rat model for acute myocardial 
infarction: application to technetium-labeled glucoheptonate, 
tetracycline, and polyphosphate. J Nucl Med. 1976;17(3):203-7.
Alexander JM, Bruneau BG. Lessons for cardiac regeneration and 
repair through development. Trends Mol Med. 2010;16(9):426-
34. 
Van Amerongen MJ, Harmsen MC, Petersen AH, Popa ER, Van 
Luyn MJA. Cryoinjury: a model of myocardial regeneration. 
Cardiovasc Pathol. 2008;17(1):23-31. 
Amran AZ, Jantan I, Dianita R, Buang F. Protective effects of 
the standardized extract of Zingiber officinale on myocardium 
against isoproterenol-induced biochemical and histopathological 
alterations in rats. Pharm Biol. 2015;53(12):1795-802. 
Atli O, Ilgin S, Altuntas H, Burukoglu D. Evaluation of 
azithromycin induced cardiotoxicity in rats. Int J Clin Exp Med. 
2015;8(3):3681-90.
Azab KS, Bashandy M, Salem M, Ahmed O, Tawfik Z, Helal 
H. Royal jelly modulates oxidative stress and tissue injury in 
gamma irradiated male Wister Albino rats. N Am J Med Sci. 
2011;3(6):268-76. 
Baş H, Kalender Y. Chlorpyrifos induced cardiotoxicity in rats 
and the protective role of quercetin and catechin. Gazi Univ J 
Sci. 2011;24(3):385-95.
Bentzon JF, Falk E. Atherosclerotic lesions in mouse and man: 
Is it the same disease? Curr Opin Lipidol. 2010;21(5):434-40. 
Chaâbane M, Tir M, Hamdi S, Boudawara O, Jamoussi 
K, Boudawara T, et al. Improvement of heart redox states 
contributes to the beneficial effects of selenium against 
penconazole-induced cardiotoxicity in adult rats. Biol Trace 
Elem Res. 2016;169(2):261-70. 
Chandrasekera PC, Pippin JJ. The human subject: an integrative 
animal model for 21(st) century heart failure research. Am J 
Transl Res. 2015;7(9):1636-47.
Conci E, Pachinger O, Metzler B. Mouse models for myocardial 
ischaemia/reperfusion. J Für Kardiol J Cardiol. 2006;13(7-
8):239-44.
Davie C, Pierre-Valentin J, Pollard C, Standen N, Mitcheson 
J, Alexander P, et al. Comparative pharmacology of guinea pig 
cardiac myocyte and cloned hERG (IKr) channel. J Cardiovasc 
Electrophysiol. 2004;15(11):1302-9.
Elkady AA, Mohamed ET. Possible role of withania somnifera 
against gamma radiation induced cardiotoxicity in male albino 
rats. Pak J Zool. 2016;48(2):539-45.
Eshaghi M, Zare S, Banihabib N, Nejati V, Farokhi F, Mikaili P. 
Cardioprotective effect of cornus mas fruit extract against carbon 
tetrachloride induced-cardiotoxicity in albino rats. J Basic Appl 
Sci Res. 2012;2(11):11106-14.
Fadillioglu E, Oztas E, Erdogan H, Yagmurca M, Sogut S, 
Ucar M, et al. Protective effects of caffeic acid phenethyl ester 
on doxorubicin-induced cardiotoxicity in rats. J Appl Toxicol. 
2004;24(1):47-52. 
Fahmy M, Elazab A, Gomaa GM, Abdo W. Protective effect of 
s-methyl cysteine against tilmicosin-induced cardiotoxicity in 
rats. Pak Vet J. 2014;34(3):253-8318.
Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective 
changes in cardiac gene expression during compensated 
hypertrophy and the transition to cardiac decompensation in 
rats with chronic aortic banding. Circ Res. 1993;73(1):184-92.
Gado AM, Nasser A, Adam I, Aldahmash BA. Cardiotoxicity 
induced by cyclophosphamide in rats: Protective effect of 
curcumin. J Res Environ Sci Toxicol. 2013;2(4):2315-5698.
Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, et al. 
A Novel and efficient model of coronary artery ligation and 
myocardial infarction in the mouse. Cir Res. 2011;107(12):1445-
53. 
A conglomeration of preclinical models related to myocardial infarction
Braz. J. Pharm. Sci. 2020;56:e18365 Page 21 / 23
Gengo PJ, Sabbah HN, Steffen RP, Sharpe JK, Kono T, Stein 
PD, et al. Myocardial beta adrenoceptor and voltage sensitive 
calcium channel changes in a canine model of chronic heart 
failure. J Mol Cell Cardiol. 1992;24(11):1361-9. 
Ghorbel I, Elwej A, Chaabane M, Jamoussi K, Zeghal N. 
Protective effect of selenium against aluminium chloride induced 
cardiotoxicity in rats. Pharm Biomed Res. 2017;3(2):19-25.
Grisel P, Meinhardt A, Lehr HA, Kappenberger L, Barrandon 
Y, Vassalli G. The MRL mouse repairs both cryogenic and 
ischemic myocardial infarcts with scar. Cardiovasc Pathol. 
2008;17(1):14-22. 
Halapas A, Papalois A, Stauropoulou A, Philippou A, Pissimissis 
N, Chatzigeorgiou A, et al. In vivo models for heart failure 
research. In Vivo. 2008;22(6):767-80.
Harada K, Grossman W, Friedman M, Edelman ER, Prasad P 
V, Keighley CS, et al. Basic fibroblast growth factor improves 
myocardial function in chronically ischemic porcine hearts949. 
J Clin Invest. 1994;94(2):623-30.
Hasenfuss G. Animal models of human cardiovascular disease, 
heart failure and hypertrophy. Cardiovasc Res. 1998;39(1):60-
76. 
Hasty AH, Shimano H, Osuga JI, Namatame I, Takahashi 
A ,  Yahag i  N,  e t  a l .  Severe  hypercho les te ro lemia , 
hypertriglyceridemia, and atherosclerosis in mice lacking both 
leptin and the low density lipoprotein receptor. J Biol Chem. 
2001;276(40):37402-8. 
Herman EH, Knapton A, Rosen E, Thompson K, Rosenzweig 
B, Estis J, et al. A multifaceted evaluation of imatinib-induced 
cardiotoxicity in the rat. Toxicol Pathol. 2011;39(7):1091-106. 
Hernando V, Inserte J, Sartório CL, Parra VM, Poncelas-Nozal 
M, Garcia-Dorado D. Calpain translocation and activation 
as pharmacological targets during myocardial ischemia/
reperfusion. J Mol Cell Cardiol. 2010;49(2):271-9. 
Hofker MH, van Vlijmen BJ, Havekes LM. Transgenic mouse 
models to study the role of APOE in hyperlipidemia and 
atherosclerosis. Atherosclerosis. 1998;137(1):1-11.
Holtz JR, Studer H, Reinecke H, Just HD. Modulation of 
myocardial sarcoplasmic reticulum Ca++ -ATPase in cardiac 
hypertrophy by angiotensin converting enzyme? Basic Res 
Cardiol. 1992;87:191-204.
Hood WB, McCarthy B, Lown B. Myocardial infarction following 
coronary ligation in dogs. Hemodynamic effects of isoproterenol 
and acetylstrophanthidin. Circ Res. 1967;21(2):191-9. 
Van Der Hoorn JWA, Jukema JW, Havekes LM, Lundholm 
E, Camejo G, Rensen PCN, et al. The dual PPARα/γ agonist 
tesaglitazar blocks progression of pre-existing atherosclerosis 
in APOE*3Leiden.CETP transgenic mice. Br J Pharmacol. 
2009;156(7):1067-75.
Hu W, Polinsky P, Sadoun E, Rosenfeld ME, Schwartz SM. 
Atherosclerotic lesions in the common coronary arteries of ApoE 
knockout mice. Cardiovasc Pathol. 2005;14(3):120-5. 
Ibrahim A, Abdel-Daim M. Modulating effects of spirulina 
platensis against tilmicosin-induced cardiotoxic-ity in mice. 
Cell J. 2015;17(1):137-144. 
Igić R. The isolated perfused “working” rat heart: A new method. 
J Pharmacol Toxicol Methods. 1996;35(2):63-7. 
Iwanaga K, Takano H, Ohtsuka M, Hasegawa H, Zou Y, Qin 
Y, et al. Effects of G-CSF on cardiac remodeling after acute 
myocardial infarction in swine. Biochem Biophys Res Commun. 
2004;325(4):1353-9.
Lee KT, Jarmolych J, Kim DN, Grant C, Krasney JA, 
Thomas WA, Bruno AM. Production of advanced coronary 
atherosclerosis, myocardial infarction and “sudden death” in 
swine. Exp Mol Pathol. 1971;15(2):170-90.
Kalender S. Effects of mercury chloride and lead nitrate 
induced cardiotoxicity in male rats. J Harran Univ Med Fac. 
2016;13:136-43.
Klocke R, Tian W, Kuhlmann MT, Nikol S. Surgical animal 
models of heart failure related to coronary heart disease. 
Cardiovasc Res. 2007;74(1):29-38.
Křikava I, Jarkovský J, Štourač P, Nováková M, Ševčík P. The 
effects of lidocaine on bupivacaine-induced cardiotoxicity in the 
isolated rat heart. Physiol Res. 2010;59(Suppl 1):S65-9.
Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Sharma 
D, Kumar V, et al. Animal models of myocardial infarction: 
Mainstay in clinical translation. Regul Toxicol Pharmacol. 
2016;76:221-30. 
de Leiris J, Harding DP, Pestre S. The isolated perfused rat heart: 
A model for studying myocardial hypoxia or ischaemia. Basic 
Res Cardiol. 1984;79(3):313-21.
F. Ahsan, T. Mahmood, S. Usmani, P. Bagga, A. Shamim, R. Tiwari, N. Verma
Braz. J. Pharm. Sci. 2020;56:e18365Page 22 / 23
Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala 
S. Characterization of atherosclerotic lesions in apo E3-leiden 
transgenic mice. Atherosclerosis. 1998;136(1):147-52. 
Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass 
CK. Peroxisome proliferator-activated receptor gamma ligands 
inhibit development of atherosclerosis in LDL receptor-deficient 
mice. J Clin Invest. 2000;106(4):523-31.
Lian Y, Gao L, Guo P, Zhao Y, Lin T. Grape seed proanthocyanidins 
extract prevents cisplatin-induced cardiotoxicity in rats. Food 
Sci Technol Res. 2016;22(3):403-8.
Linz W, Scholkens BA, Manwen J, Wilhelm M GD. The heart 
as a target for converting enzyme-inhibitors-studies in ischemic 
isolated working rat hearts. J Hypertens. 1986;4:S477-9.
Lipp. Cardiotoxicity of cytotoxic drugs. Anticancer drug 
toxicity. Prevention, management and clinical pharmacokinetics. 
New York: Marcel Dekker; 1991.
Liu YH, Yang XP, Nass O, Sabbah HN, Peterson E, Carretero 
OA. Chronic heart failure induced by coronary artery ligation 
in Lewis inbred rats. Am J Physiol. 1997;272(2 Pt 2):H722-7. 
Martorana PA, Linz W, Göbel H, Petry P, Schölkens BA. Effects 
of nicainoprol on reperfusion arrhythmia in the isolated working 
rat heart and on ischemia and reperfusion arrhythmia and 
myocardial infarct size in the anesthetized rat. Eur J Pharmacol. 
1987;143(3):391-401.
Mezni A, Aoua H, Khazri O, Limam F, Aouani E. Lithium 
induced oxidative damage and inflammation in the rat’s heart: 
Protective effect of grape seed and skin extract. Biomed 
Pharmacother. 2017;95:1103-11.
Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall 
SR, et al. Myocardial ischemia and reperfusion: a murine model. 
Am J Physiol. 1995;269(6 Pt 2):H2147-54. 
Miller DL, Van Winkle DM. Ischemic preconditioning limits 
infarct size following regional ischemia-reperfusion in in situ 
mouse hearts. Cardiovasc Res. 1999;42(3):680-4.
Murry CE, Jennings RB, Reimer KA. Preconditioning with 
ischemia : injury delay of lethal cell ischemic myocardium. 
Circulation. 1986;74(5):1224-1136.
Murry CE, Kay MA, Bartosek T, Hauschka SD, Schwartz SM. 
Muscle differentiation during repair of myocardial necrosis in 
rats via gene transfer with MyoD. J Clin Invest. 1996;98:2209-17.
Oguzturk H, Ciftci O, Cetin A, Kaya K, Disli OM, Turtay 
MG. Beneficial effects of hesperidin following cis - 
diamminedichloroplatinum - induced damage in heart of rats. 
Niger J Clin Pract. 2016;19(1):99-103.
Oliveira MG, Passos LC, Santos Júnior EG, Barbosa AC, Santos 
DB. Use of an indicator to evaluate physician adherence to 
prescription guidelines for the treatment of heart failure. Braz J 
Pharm Sci. 2013;49(4):831-836.
Páez MT, Catalina Rodríguez D, López DF, Castañeda JA, 
Buitrago DM, Cuca LE, et al. Croton schiedeanus Schltd 
prevents experimental hypertension in rats induced by nitric 
oxide deficit. Braz J Pharm Sci. 2013;49(4):865-871.
Partownavid P, Sharma S, Rahman S, Eghbali M. Intralipid 
rescue of bupivacaine-induced cardiotoxicity in rats is 
abolished by glibenclamide, an ATP potassium channel blocker. 
Circulation. 2013;128.
Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro 
J, Kloner RA, et al. Myocardial infarct size and ventricular 
function in rats. Circ Res. 1979;44(4):503-12. 
Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh 
A, Verstuyft JG, et al. Severe hypercholesterolemia and 
atherosclerosis in apolipoprotein E-deficient mice created by 
homologous recombination in ES cells. Cell. 1992;71(2):343-
53.
Reeve JLV, Duffy AM, O’Brien T, Samali A. Don’t lose heart 
- therapeutic value of apoptosis prevention in the treatment of 
cardiovascular disease. J Cell Mol Med. 2005;9(3):609-22. 
Reffelmann T, Sensebat O, Birnbaum Y, Stroemer E, Hanrath P, 
Uretsky BF, et al. A novel minimal-invasive model of chronic 
myocardial infarction in swine. Coron Artery Dis. 2004;15(1):7-
12. 
Robey TE, Murry CE. Absence of regeneration in the MRL/
MpJ mouse heart following infarction or cryoinjury. Cardiovasc 
Pathol. 2008;17(1):6-13. 
Rona G, Kahn DS. Experimental studies on the healing of 
cardiac necrosis. Ann N Y Acad Sci. 1969;156:177–88. 
Roos KP, Brady AJ. Individual sarcomere length determination 
from isolated cardiac cells using high-resolution optical 
microscopy and digital image processing. Biophys J. 
1982;40(3):233-44.
A conglomeration of preclinical models related to myocardial infarction
Braz. J. Pharm. Sci. 2020;56:e18365 Page 23 / 23
Roth DM, White FC, Mathieu-Costello O, Guth BD, Heusch G, 
Bloor CM, et al. Effects of left circumflex Ameroid constrictor 
placement on adrenergic innervation of myocardium. Am J 
Physiol. 1987;253(6 Pt 2):H1425-34.
 
Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, 
Jafri S, et al. A canine model of chronic heart failure produced 
by multiple sequential coronary microembolizations. Am J 
Physiol. 1991;260(4 Pt 2):H1379-84. 
Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser 
V, et al. Low density lipoprotein receptor-negative mice 
expressing human apolipoprotein B-100 develop complex 
atherosclerotic lesions on a chow diet: no accentuation by 
apolipoprotein(a). Proc Natl Acad Sci. 1998;95(8):4544-9. 
Schimmel KJM, Richel DJ, van den Brink RBA, Guchelaar 
HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 
2004;30(2):181-91.
Scholz W, Albus U, Lang HJ, Linz W, Martorana PA, Englert 
HC, et al. Hoe 694, a new Na+/H+exchange inhibitor and its 
effects in cardiac ischaemia. Br J Pharmacol. 1993;109(2):562-8. 
Scholz W, Albus U, Linz W, Martorana P, Lang HJ, Schölkens 
BA. Effects of Na+/H+ exchange inhibitors in cardiac ischemia. 
J Mol Cell Cardiol. 1992;24(7):731-9. 
Shahzadi A, Sonmez I, Allahverdi O, Onal B, Kandaz C, 
Ozyazgan SO, et al. Cardiac Troponin-I (cTnI) a biomarker 
of cardiac injuries induced by doxorubicin alone and in 
combination with ciprofloxacin, following acute and chronic 
dose protocol in sprague dawley rats. Int J Pharmacol. 
2014;10(5):258-66.
Srikanth G, Prakash P, Tripathy N, Dikshit M, Nityanand S. 
Establishment of a rat model of myocardial infarction with a 
high survival rate: A suitable model for evaluation of efficacy 
of stem cell therapy. J Stem Cells Regen Med. 2009;5(1):30-6.
St Louis JD, Hughes GC, Kypson AP, DeGrado TR, Donovan 
CL, Coleman RE, et al. An experimental model of chronic 
myocardial hibernation. Ann Thorac Surg. 2000;69(5):1351-7.
Thomas NP, Johns BJO. Experimental myocardial infarction: 
I. A method of coronary occlusion in small animals. Ann Surg. 
1954;140(5):675-82.
Uttam Paul SG. Study of cardioprotective activity of normovedic 
in Ccl4 induced cardiotoxicity in rats. Int J Pharma Bio Sci. 
2016;7(3):135-43.
Vandervelde S, Van Amerongen MJ, Tio RA, Petersen AH, Van 
Luyn MJA, Harmsen MC. Increased inflammatory response 
and neovascularization in reperfused vs. nonreperfused murine 
myocardial infarction. Cardiovasc Pathol. 2006;15(2):83-90. 
Véniant MM, Zlot CH, Walzem RL, Pierotti V, Driscoll R, 
Dichek D, et al. Lipoprotein clearance mechanisms in LDL 
receptor-deficient “apo-B48- only” and “apo-B100-only” mice. 
J Clin Invest. 1998;102(8):1559-68. 
Verdouw PD, van den Doel MA, de Zeeuw S, Duncker DJ. 
Animal models in the study of myocardial ischaemia and 
ischaemic syndromes. Cardiovasc Res. 1998;39(1):121-35. 
Viswanatha Swamy AHM, Patel UM, Koti BC, Gadad PC, Patel 
NL, Thippeswamy AHM. Cardioprotective effect of Saraca 
indica against cyclophosphamide induced cardiotoxicity in rats: 
a biochemical, electrocardiographic and histopathological study. 
Indian J Pharmacol. 2013;45(1):44-8. 
Vleeming W, Van Der Wouw PA, Van Rooij HH, Wemer J. 
In vitro method for measurement of cardiac performance and 
responses to lnotropic drugs after experimentally induced 
myocardial infarction in the rat. J Pharmacol Methods. 
1989;21:95-102.
Vogel H, editor. Drug discovery and evaluation: pharmacological 
assays. Springer Science & Business Media; 2007.
Yu JZ, Rodrigues B, McNeill JH. Intracellular calcium levels are 
unchanged in the diabetic heart. Cardiovasc Res. 1997;34(1):91-
8.
Zadelaar S, Kleemann R, Verschuren L, De Vries-Van Der 
Weij J, Van Der Hoorn J, Princen HM, et al. Mouse models 
for atherosclerosis and pharmaceutical modifiers. Arterioscler 
Thromb Vasc Biol. 2007;27(8):1706-21. 
Zaragoza  C ,  Gomez-Guer r e ro  C ,  Mar t i n -Ven tu ra 
JL, Blanco-Colio L, Lavin B, Mallavia B, et al. Animal 
models of cardiovascular diseases. J Biomed Biotechnol. 
2011;2011:497841.
Received for publication on 21st May 2018
Accepted for publication on 10th July 2018
This is an open-access article distributed under the terms of the Creative Commons Attribution License.
